![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
01 ACCORD HEALTHCARE LIMITED (1)
02 AMGEN EUROPE B.V. (3)
03 Accord Healthcare AG (5)
04 Amgen Europe B.V. (6)
05 Amgen Switzerland AG (3)
06 HOSPIRA UK LTD (3)
07 Hospira UK Limited (3)
08 Orifarm AS (1)
09 Ratiopharm GmbH (2)
10 SANDOZ GMBH (2)
11 Sandoz GmbH (2)
12 Sandoz Pharmaceuticals AG (2)
13 TEVA GmbH (2)
14 Teva Generics GmbH (2)
15 Teva Pharma AG (4)
16 UAB "Sicor Biotech" (1)
17 UAB SICOR BIOTECH (1)
01 FILGRASTIM (29)
02 Filgrastimum ADNr (14)
01 Italy (12)
02 Norway (17)
03 Switzerland (14)
01 Filgrastim 12,000.000Iu 0.2Ml 1 Unit Parenteral Use (1)
02 Filgrastim 30,000.000Iu 1 Unit Parenteral Use (6)
03 Filgrastim 30,000.000Iu 5 Units Parenteral Use (1)
04 Filgrastim 48,000.000Iu 1 Unit Parenteral Use (2)
05 Inj L?s (3)
06 Inj Loose (2)
07 Inj Sol (4)
08 Inj Solution (2)
09 Inj. Soluble (1)
10 Inj. Solution (2)
11 Injection fluid, resolution (3)
12 Injection fluid, resolution/concentrate to the infusion fluid (4)
13 Injection/infusion fluid, resolution (10)
14 Lipegfilgrastim 6Mg 1 Unit Parenteral Use (1)
15 Pegfilgrastim 6Mg 1 Unit Parenteral Use (1)